Mitchell, SC, Korones, SB, Berendes, HW. Congenital heart disease in 56,109 births. Incidence and natural history. Circulation
1971; 43: 323–332.
Pierpont, ME, Basson, CT, Benson, DW Jr, et al. Genetic basis for congenital heart defects: current knowledge: a scientific statement from the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: endorsed by the American Academy of Pediatrics. Circulation
2007; 115: 3015–3038.
Srivastava, D. Making or breaking the heart: from lineage determination to morphogenesis. Cell
2006; 126: 1037–1048.
Chinawa, JM, Obu, HA, Eke, CB, Eze, JC. Pattern and clinical profile of children with complex cardiac anomaly at University of Nigeria Teaching Hospital, Ituku-Ozalla, Enugu State, Nigeria. Niger J Clin Pract
2013; 16: 462–467.
Hoffman, JI, Kaplan, S. The incidence of congenital heart disease. J Am Coll Cardiol
2002; 39: 1890–1900.
Geva, T, Martins, JD, Wald, RM. Atrial septal defects. Lancet
2014; 383: 1921–1932.
Maitra, M, Schluterman, MK, Nichols, HA, et al. Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol
2009; 326: 368–377.
Hoffman, JI. Incidence of congenital heart disease: I. Postnatal incidence. Pediatr Cardiol
1995; 16: 103–113.
Garg, V, Kathiriya, IS, Barnes, R, et al. GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature
2003; 424: 443–447.
Gong, W, Gottlieb, S, Collins, J, et al. Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet
2001; 38: E45.
Schott, JJ, Benson, DW, Basson, CT, et al. Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science
1998; 281: 108–111.
Ostojic, S, Dubanchet, S, Chaouat, G, Abdelkarim, M, Truyens, C, Capron, F. Demonstration of the presence of IL-16, IL-17 and IL-18 at the murine fetomaternal interface during murine pregnancy. Am J Reprod Immunol
2003; 49: 101–112.
Rodriguez-Burgos, A, Juarez, L. Developmental delay and other anomalies in the offspring from hens immunized against soluble and foreign chick embryo antigens. Am J Reprod Immunol
2008; 60: 141–150.
Murugaiyan, G, Saha, B. IL-27 in tumor immunity and immunotherapy. Trends Mol Med
2013; 19: 108–116.
Pflanz, S, Timans, JC, Cheung, J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4(+) T cells. Immunity
2002; 16: 779–790.
Devergne, O, Hummel, M, Koeppen, H, et al. A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytes. J Virol
1996; 70: 1143–1153.
Pflanz, S, Hibbert, L, Mattson, J, et al. WSX-1 and glycoprotein 130 constitute a signal-transducing receptor for IL-27. J Immunol
2004; 172: 2225–2231.
Zhang, Z, Zhou, B, Wu, Y, et al. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics
2014; 66: 85–92.
Laird, SM, Tuckerman, EM, Li, TC. Cytokine expression in the endometrium of women with implantation failure and recurrent miscarriage. Reprod Biomed Online
2006; 13: 13–23.
Coulomb-L’Hermine, A, Larousserie, F, Pflanz, S, Bardel, E, Kastelein, RA, Devergne, O. Expression of interleukin-27 by human trophoblast cells. Placenta
2007; 28: 1133–1140.
Shi, S, Zhou, B, Zhang, K, Zhang, L. Association between two genetic variants of CD226 gene and Cervical Squamous Cell Carcinoma: a case-control study. Gene
2013; 519: 159–163.
Tao, YP, Wang, WL, Li, SY, et al. Associations between polymorphisms in IL-12A, IL-12B, IL-12Rbeta1, IL-27 gene and serum levels of IL-12p40, IL-27p28 with esophageal cancer. J Cancer Res Clin Oncol
2012; 138: 1891–1900.
Shen, Y, Yuan, XD, Hu, D, et al. Association between Interleukin-27 gene polymorphisms and susceptibility to allergic rhinitis. Hum Immunol
2014; 75: 991–995.
Huang, N, Liu, L, Wang, XZ, Liu, D, Yin, SY, Yang, XD. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol
2008; 27: 527–531.
Sole, X, Guino, E, Valls, J, Iniesta, R, Moreno, V. SNPStats: a web tool for the analysis of association studies. Bioinformatics
2006; 22: 1928–1929.
Mas, AE, Petitbarat, M, Dubanchet, S, Fay, S, Ledee, N, Chaouat, G. Immune regulation at the interface during early steps of murine implantation: involvement of two new cytokines of the IL-12 family (IL-23 and IL-27) and of TWEAK. Am J Reprod Immunol
2008; 59: 323–338.
Cleves, MA, Malik, S, Yang, S, Carter, TC, Hobbs, CA. Maternal urinary tract infections and selected cardiovascular malformations. Birth Defects Res A Clin Mol Teratol
2008; 82: 464–473.
Blossom, SJ, Rau, JL, Best, TH, Bornemeier, RA, Hobbs, CA. Increased maternal cytokine production and congenital heart defects. J Reprod Immunol
2013; 97: 204–210.
Mann, DL, Young, JB. Basic mechanisms in congestive heart failure. Recognizing the role of proinflammatory cytokines. Chest
1994; 105: 897–904.
Kriszbacher, I, Koppan, M, Bodis, J. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med
2005; 353: 429–430.
Werdan, K. The activated immune system in congestive heart failure – from dropsy to the cytokine paradigm. J Intern Med
1998; 243: 87–92.
Buchhorn, R, Wessel, A, Hulpke-Wette, M, Bursch, J, Werdan, K, Loppnow, H. Endogenous nitric oxide and soluble tumor necrosis factor receptor levels are enhanced in infants with congenital heart disease. Crit Care Med
2001; 29: 2208–2210.
Devergne, O, Birkenbach, M, Kieff, E. Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin. Proc Natl Acad Sci U S A
1997; 94: 12041–12046.
Devergne, O, Coulomb-L’Hermine, A, Capel, F, Moussa, M, Capron, F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: involvement of syncytiotrophoblasts and extravillous trophoblasts. Am J Pathol
2001; 159: 1763–1776.
Hunter, CA. New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions. Nat Rev Immunol
2005; 5: 521–531.
Gee, K, Guzzo, C, Che Mat, NF, Ma, W, Kumar, A. The IL-12 family of cytokines in infection, inflammation and autoimmune disorders. Inflamm Allergy Drug Targets
2009; 8: 40–52.
Shimizu, M, Shimamura, M, Owaki, T, et al. Antiangiogenic and antitumor activities of IL-27. J Immunol
2006; 176: 7317–7324.